CAPECITABINA GLENMARK 150mg film-coated tablets
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
letter C · page 11
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
capecitabine Indicated for: cancer
L01BC06 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues